A further explanation for the differential binding of CD47 mAbs to cancer versus normal cells lies in potential differences in surface mobility of CD47 on different cell types [40] or different densities or distribution of CD47 in the lipid rafts [41]. The gene discussed is CD47; the disease is cancer.